torcetrapib has been researched along with rifamycins in 1 studies
Studies (torcetrapib) | Trials (torcetrapib) | Recent Studies (post-2010) (torcetrapib) | Studies (rifamycins) | Trials (rifamycins) | Recent Studies (post-2010) (rifamycins) |
---|---|---|---|---|---|
273 | 28 | 83 | 2,351 | 203 | 626 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Powell, JT | 1 |
1 other study(ies) available for torcetrapib and rifamycins
Article | Year |
---|---|
Three drug indications for patients with peripheral arterial disease bite the dust: report from the American Heart Association meeting 2007 in Orlando.
Topics: Adrenergic beta-Antagonists; American Heart Association; Anti-Bacterial Agents; Anticholesteremic Agents; Humans; Metoprolol; Peripheral Vascular Diseases; Practice Guidelines as Topic; Quinolines; Rifamycins; United States | 2008 |